JPRN-UMIN000013048已完成未知
The study for efficacy of teneligliptin in non-alcoholic fatty liver disease (NAFLD) with type 2 diabetes mellitus - The study for efficacy of teneligliptin in non-alcoholic fatty liver disease (NAFLD) with type 2 diabetes mellitus
Sapporo Kosei General Hospital, Department of Hepatology0 个研究点目标入组 100 人开始时间: 2014年2月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) intake more than 20g/day of ethanol 2) HBsAg and/or HCV Ab positive 3) history of hepatic disease, such as autoimmune liver disease, hemochromatosis and Wilson's disease 4) history of diabetes ketosis and/or diabetic coma 5) during pregnancy
研究者
相似试验
已完成
4 期
Clinical Study for the Effect of Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes MellitusType 2 Diabetes MellitusJPRN-UMIN000014589TOPLEVEL study office936
进行中（未招募）
4 期
TOPLEVEL studyType 2 Diabetes MellitusJPRN-jRCTs051180136Kitakaze Masafumi936
尚未招募
3 期
Study on Obesity management in non diabeticsCTRI/2020/02/023329Self financed
已完成
不适用
Efficacy and safety of teneligliptin in patients with type 2 diabetes who responded insufficiently to dipeptidyl peptidase-4 (DPP-4) inhibitorsJPRN-UMIN000014298aka Kinen Clinic20
已完成
不适用
The examination of the effects of Teneligliptin on blood glucose and albuminuria in type 2 diabetic patients with nephropathy, whose glycemic control is insufficient.Type 2 diabetic patients with nephropathyJPRN-UMIN000015922Kanazawa Medical University50